Summary:
Recently, the China National Intellectual Property Administration (CNIPA) has issued the Work Plan for the Nationwide Administrative Protection of Intellectual Property in 2024 (the "Plan").
Summary:
Recently, the Ministry of Finance (MOF) and the Ministry of Industry and Information Technology (MIIT) have jointly released the Circular on Strengthening Audit Report Verification and Enhancing the Service Management for Specialized, Sophisticated, Distinctive, and Innovative "Little Giant" Enterprises (the "Circular"), effective from the date of release.
Summary:
The Ministry of Finance (MOF) and the State Taxation Administration (STA) have jointly released the Announcement on the Land Appreciation Tax Policy for the Reform of the Rural Collective Property Rights System (the "Announcement"), with effect from January 1, 2024.
Summary:
The National Financial Regulatory Administration (NFRA) has recently issued the Guiding Opinions on Promoting the High-quality Development of Green Insurance (the "Opinions").
Summary:
Recently, the State Tobacco Monopoly Administration (STMA) has issued the revised Rules for the Electronic Cigarette Trading Management (Draft for Comment) (the "Draft"), the Rules for the Electronic Cigarette Logistics Management (Draft for Comment) and the Rules for the Management of Investment in Electronic Cigarette Fixed Assets (Draft for Comment). These drafts are currently open for public comments until May 8, 2024.
Summary:
Recently, the National Healthcare Security Administration (NHSA) has developed and issued the Code of Conduct for Voluntary Supervisors of Centralized Medicine Procurement (Interim) (the "Code").
Summary:
The Supreme People's Procuratorate (SPP) has recently distributed the Circular on Issuing the Typical Cases of Procuratorial Organs on Protection of Intellectual Property Rights (the "Circular").
Summary:
Five departments, including the Ministry of Commerce (MOFCOM), have jointly released the Announcement on Adjusting the Catalogue of Precursor Chemicals Exported to Particular Countries (Regions) (the "Announcement"), with effect as of May 1, 2024.
Summary:
The National Medical Products Administration (NMPA) has released the Announcement on Relevant Matters Concerning Optimizing the Application for Marketing Authorization of Overseas-Manufactured Drugs Already Marketed Domestically to Be Shifted to Domestic Manufacturing (the "Announcement").
Summary:
Recently, the State Administration for Market Regulation (SAMR) and four other authorities have jointly issued the Administrative Measures for Testing and Evaluation of China's First (Set of) Major Technical Equipment (for Trial Implementation) (the "Measures"), effective from the date of release.